✦ LIBER ✦

Screening for pharmacological chaperones in Fabry disease

✍ Scribed by Sang-Hoon Shin; Gary J. Murray; Stefanie Kluepfel-Stahl; Adele M. Cooney; Jane M. Quirk; Raphael Schiffmann; Roscoe O. Brady; Christine R. Kaneski

Book ID: 116295037
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 176 KB
Volume: 359
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2007.05.082

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

50. The pharmacological chaperone AT1001

50. The pharmacological chaperone AT1001 and treatment of Fabry disease

✍ Richie Khanna; Elfrida R. Benjamin; Rebecca Soska; Yi Lun; Sheela A. Sitaraman; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 42 KB

260 SCREENING FOR FABRY DISEASE

✍ K. Arning; D. Naleschinski; P. Kropp; A. Binder; R. Maag; R. Baron 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 63 KB

ChemInform Abstract: Tuning Glycosidase

ChemInform Abstract: Tuning Glycosidase Inhibition Through Aglycone Interactions: Pharmacological Chaperones for Fabry Disease and GM1 Gangliosidosis.

✍ C. Ortiz Mellet; et al. et al. 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 24 KB

Screening for pompe disease and fabry di

Screening for pompe disease and fabry disease

✍ Wuh-Liang Hwu; Yin-Hsiu Chien; Ni-Chung Lee 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Pharmacological chaperones: potential tr

Pharmacological chaperones: potential treatment for conformational diseases

✍ Virginie Bernier; Monique Lagacé; Daniel G Bichet; Michel Bouvier 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 550 KB

23. Pharmacological chaperone treatment

23. Pharmacological chaperone treatment for Pompe disease

✍ Hung Do; John Flanagan; Xiaoyang Wu; Allan Powe; Richie Khana; Rebecca Soska; We 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 42 KB